Shlomit Yust-Katz

Summary

Publications

  1. ncbi Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients
    Lior H Katz
    Hepatology and Nutrition Department, MD Anderdson Cancer Center, Houston, Texas, USA
    Cochrane Database Syst Rev 9:CD008516. 2012
  2. ncbi Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis
    L H Katz
    Medical Corps, Israel Defense Forces, Aviv, Israel
    Clin Microbiol Infect 13:943-6. 2007
  3. ncbi Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis
    L H Katz
    Department of Medicine D and Liver Institute, Beilinson Campus, Rabin Medical Center, Petah Tiqva, Israel
    J Viral Hepat 15:89-102. 2008
  4. ncbi Long-term Parkinson's disease--time for optimism
    Shlomit Yust-Katz
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Biomed Pharmacother 62:233-5. 2008
  5. ncbi Handedness as a predictor of side of onset of Parkinson's disease
    Shlomit Yust-Katz
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa 49100, Israel
    Parkinsonism Relat Disord 14:633-5. 2008
  6. ncbi Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
    L H Katz
    Liver Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
    Transpl Infect Dis 12:292-308. 2010
  7. ncbi Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism
    Shlomit Yust-Katz
    Department of Neurology, Movement Disorders Clinic, Rabin Medical Center, 49100 Petach Tikva, Israel
    J Neural Transm 119:73-6. 2012
  8. ncbi Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress
    Shlomit Yust-Katz
    Department of Neurology, Hospital for Women, Rabin Medical Center, Petah Tiqwa 49100, Israel
    Cytotherapy 14:45-55. 2012
  9. ncbi The effect of duloxetine on primary pain symptoms in Parkinson disease
    Ruth Djaldetti
    Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Clin Neuropharmacol 30:201-5. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients
    Lior H Katz
    Hepatology and Nutrition Department, MD Anderdson Cancer Center, Houston, Texas, USA
    Cochrane Database Syst Rev 9:CD008516. 2012
    ..However, the number of patients demonstrating a sustained virological response is not high. In order to improve sustained virological response, extending the length of the treatment period has been suggested...
  2. ncbi Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis
    L H Katz
    Medical Corps, Israel Defense Forces, Aviv, Israel
    Clin Microbiol Infect 13:943-6. 2007
    ..Mass antibiotic prophylaxis initially suppressed meningococcal carriage, but the carriage rate subsequently rebounded...
  3. ncbi Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis
    L H Katz
    Department of Medicine D and Liver Institute, Beilinson Campus, Rabin Medical Center, Petah Tiqva, Israel
    J Viral Hepat 15:89-102. 2008
    ..Lamivudine should be administered prophylactically to HBsAg-positive patients who are about to receive immunosuppressive therapy...
  4. ncbi Long-term Parkinson's disease--time for optimism
    Shlomit Yust-Katz
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Biomed Pharmacother 62:233-5. 2008
    ..In conclusion, PD has a chronic progressive course, although most patients do not reach end-stage disease. The effect of L-dopa treatment decreases over time, but is not lost completely...
  5. ncbi Handedness as a predictor of side of onset of Parkinson's disease
    Shlomit Yust-Katz
    Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa 49100, Israel
    Parkinsonism Relat Disord 14:633-5. 2008
    ..06]. In conclusion, Parkinson's disease appears to be characterized by asymmetry of symptoms. There was a trend toward symptoms onset on the dominant side...
  6. ncbi Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
    L H Katz
    Liver Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
    Transpl Infect Dis 12:292-308. 2010
    ..To evaluate antiviral prophylaxis against hepatitis B virus (HBV) following liver transplantation...
  7. ncbi Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism
    Shlomit Yust-Katz
    Department of Neurology, Movement Disorders Clinic, Rabin Medical Center, 49100 Petach Tikva, Israel
    J Neural Transm 119:73-6. 2012
    ..Dyspnea and respiratory distress should be included among the non-motor symptoms of parkinsonism...
  8. ncbi Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress
    Shlomit Yust-Katz
    Department of Neurology, Hospital for Women, Rabin Medical Center, Petah Tiqwa 49100, Israel
    Cytotherapy 14:45-55. 2012
    ..The aim of this study was to evaluate the capacity of induced placental MSC to differentiate into neurotrophic factor-producing cells (NTF) and their protective effect on neuronal cells...
  9. ncbi The effect of duloxetine on primary pain symptoms in Parkinson disease
    Ruth Djaldetti
    Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Clin Neuropharmacol 30:201-5. 2007
    ..To study the effect of duloxetine (Cymbalta), a selective serotonin and norepinephrine reuptake inhibitor, on pain symptoms in Parkinson Disease (PD)...